Antioxidative defence capacity in sporadic Alzheimer's disease and in transgenic mice overexpressing amyloid-beta

被引：0
|
作者：
Schüssel, K
Leutner, S
Cairns, NJ
Czech, C
Pradier, L
Müller, WE
Eckert, A
机构：
[1] Univ Frankfurt, Dept Pharmacol, Bioctr, D-6000 Frankfurt, Germany
[2] Inst Psychiat, MRC, Alzheimers Dis Bank, London, England
[3] Hoffmann La Roche Ag, CNS Res, CH-4070 Basel, Switzerland
[4] Aventis Pharma, Res & Dev, F-94403 Vitry Sur Seine, France
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2003年 / 367卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
335
引用
收藏
页码：R87 / R87
页数：1
相关论文
共 50 条
  • [21] Amyloid-beta and tau protein beyond Alzheimer's disease
    Abyadeh, Morteza
    Gupta, Vivek
    Paulo, Joao A.
    Mahmoudabad, Arezoo Gohari
    Shadfar, Sina
    Mirshahvaladi, Shahab
    Gupta, Veer
    Nguyen, Christine T. O.
    Finkelstein, David I.
    You, Yuyi
    Haynes, Paul A.
    Salekdeh, Ghasem H.
    Graham, Stuart L.
    Mirzaei, Mehdi
    NEURAL REGENERATION RESEARCH, 2024, 19 (06) : 1262 - 1276
  • [22] Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease
    Dorey, Evan
    Chang, Nina
    Liu, Qing Yan
    Yang, Ze
    Zhang, Wandong
    NEUROSCIENCE BULLETIN, 2014, 30 (02) : 317 - 330
  • [23] Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease
    Evan Dorey
    Nina Chang
    Qing Yan Liu
    Ze Yang
    Wandong Zhang
    Neuroscience Bulletin, 2014, 30 (02) : 317 - 330
  • [24] Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer's Disease
    He, Chuan
    Huang, Zhong-sheng
    Yu, Chao-chao
    Wang, Hai-hua
    Zhou, Hua
    Kong, Li-hong
    CURRENT MEDICAL SCIENCE, 2020, 40 (06): : 1022 - 1030
  • [25] PET amyloid-beta imaging in preclinical Alzheimer's disease
    Vlassenko, Andrei G.
    Benzinger, Tammie L. S.
    Morris, John C.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (03): : 370 - 379
  • [26] Impaired hepatic amyloid-beta degradation in Alzheimer's disease
    Maarouf, Chera L.
    Walker, Jessica E.
    Sue, Lucia I.
    Dugger, Brittany N.
    Beach, Thomas G.
    Serrano, Geidy E.
    PLOS ONE, 2018, 13 (09):
  • [27] Quantitative in vivo assessment of amyloid-beta phagocytic capacity in an Alzheimer's disease mouse model
    Lau, Shun-Fat
    Wu, Wei
    Seo, Heukjin
    Fu, Amy K. Y.
    Ip, Nancy Y.
    STAR PROTOCOLS, 2021, 2 (01):
  • [28] Plasma amyloid-beta and serum amyloid-beta auto-antibody levels in patients with Alzheimer's disease
    Zhou, L.
    Chu, L. W.
    Kwan, J. S. C.
    Lam, K. S. L.
    Cheng, O. Y.
    Chan, K. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 98 - 98
  • [29] Amyloid-beta immunotherapy: the hope for Alzheimer disease?
    Barrera-Ocampo, Alvaro
    Lopera, Francisco
    COLOMBIA MEDICA, 2016, 47 (04): : 203 - 212
  • [30] Neurogenic responses to amyloid-beta plaques in the brain of Alzheimer's disease-like transgenic (pPDGF-APPSW,Ind) mice
    Gan, Li
    Qiao, Shuhong
    Lan, Xun
    Chi, Liying
    Luo, Chun
    Lien, Lindsey
    Liu, Qing Yan
    Liu, Rugao
    NEUROBIOLOGY OF DISEASE, 2008, 29 (01) : 71 - 80
12345